Literature DB >> 22381923

Inflammation is related to unbalanced cardiac autonomic functions in hypertension: an observational study.

Ataç Celik1, Fatih Koç, Hasan Kadi, Köksal Ceyhan, Unal Erkorkmaz.   

Abstract

OBJECTIVE: Inflammation plays a role both in the mechanisms leading to hypertension alone and in the mechanisms leading to atherosclerosis with hypertension. Previous studies have shown the relationship between the autonomic functions and inflammatory system activation. The aim of the study was to evaluate the relationship between inflammation and cardiac autonomic functions in hypertensive patients.
METHODS: One hundred twenty one hypertensive patients (mean age 59 ± 11 years, 60 male) and 34 healthy volunteers (mean age 58 ± 11 years, 18 male) were included in the present cross-sectional observational study. The 24-hour ambulatory electrocardiogram recordings were taken using Pathfinder Software. The heart rate variability (HRV) analysis was performed using time domain parameters using the same software. Heart rate turbulence (HRT) parameters, turbulence onset and turbulence slope were calculated with HRT software. Statistical analysis was performed using unpaired t-test or Mann-Whitney U test, one-way ANOVA or Kruskal-Wallis analysis of variance, Chi-square test, and Spearman rank order correlation analysis. The association of hypertension with high sensitivity C-reactive protein (hs-CRP), HRV and HRT was analyzed after adjustment for confounding variables as age and creatinine levels.
RESULTS: The mean hs-CRP was higher, HRV was slightly reduced while HRT was markedly blunted in hypertensive patients in comparison with control group [SDNN; 132 ± 28 vs. 112 ± 34 msec, RMSSD; 27 (23-35) vs. 22 (16-28) msec, TO; -2.80 ± 2.15 vs. -0.96 ± 2.36%, TS; 7.56 (5.24-10.60) vs. 4.65 (2.44-7.26) msec/RR, p<0.01 for all]. All of the HRV and HRT parameters were more deteriorated in the highest tertile hs-CRP group [SDNN; 93 ± 34 msec, RMSSD; 17 (13-22) msec, TO; 0.03 ± 2.22%, TS; 2.43 (1.84-3.89) msec/RR, p<0.05 for all]. There were correlations between hs-CRP and HRV and HRT parameters (SDNN; r=-0.690, RMSSD; r=-0.277, TS; r:-0.417, TO; r=0.267, p<0.05 for all).
CONCLUSION: There is an inflammatory process in hypertensive patients and inflammation is related with unbalanced cardiac autonomic functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381923     DOI: 10.5152/akd.2012.067

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  5 in total

1.  Endogenous Estrogen-Mediated Heme Oxygenase Regulation in Experimental Menopause.

Authors:  Anikó Pósa; Renáta Szabó; Anett Csonka; Médea Veszelka; Anikó Magyariné Berkó; Zoltán Baráth; Rudolf Ménesi; Imre Pávó; Mariann Gyöngyösi; Ferenc László; Krisztina Kupai; Csaba Varga
Journal:  Oxid Med Cell Longev       Date:  2015-05-06       Impact factor: 6.543

2.  Assessment of heart rate turbulence in hypertensive patients: rationale, perspectives, and insight into autonomic nervous system dysfunction.

Authors:  Antoine Kossaify; Annie Garcia; Fouad Ziade
Journal:  Heart Views       Date:  2014-07

3.  Decreases in heart rate variability are associated with postoperative complications in hip fracture patients.

Authors:  Gernot Ernst; Leiv Otto Watne; Frede Frihagen; Torgeir Bruun Wyller; Andreas Dominik; Morten Rostrup
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

4.  Low Heart Rate Variability Predicts Stroke and Other Complications in the First Six Postoperative Months After a Hip Fracture Operation.

Authors:  Gernot Ernst; Leiv Otto Watne; Frede Frihagen; Torgeier Bruun Wyller; Andreas Dominik; Morten Rostrup
Journal:  Front Cardiovasc Med       Date:  2021-03-22

5.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.